Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression
详细信息查看全文 | 推荐本文 |
摘要
>Objectives.

Features of deregulated Notch1 signaling and NF-κB activation have independently been reported in cervical cancers. Here, we have extended these observations and examined both these pathways simultaneously in human cervical cancer tissue. Further, we have investigated the potential cross-talk between these pathways in a human cervical cancer derived cell line CaSki, which mirrors features of Notch activation as in the majority of human cervical cancers.

Methods.

Cervical tissue samples were analyzed for the expression of Notch1, Jagged 1, Hes1, pAKT, NF-κB p50, NF-κB p65, IκB-α, Bcl-2, CyclinD1, Cdk9, c-Fos, and p53 by immunohistochemistry. A total of 352 samples were analyzed which included 69 normal cervical tissue, 132 preinvasive lesions and 151 squamous cell carcinomas of the uterine cervix. Dual immunofluorescent analysis was performed to evaluate the coexpression of Notch1 and NF-κB. Transcriptional reporter assays and xenografts were undertaken with CaSki cells.

Results.

Features of Notch1 activation as measured by intracellular Notch1, high levels of Jagged1, Hes1 and Cdk9 were paralleled by nuclear translocation of both NF-κB p50 and p65 with target gene expression (IκB-α, Bcl-2, and CyclinD1) in human cervical cancer sections. Reporter assays in CaSki cells are consistent with Notch being an upstream regulator of NF-κB. Further, the xenografts recreate key aspects of human cancer tissue.

Conclusions.

Results from this study suggest that there is a co-activation of Notch1 and NF-κB signaling pathways at the cellular level in the majority of human cervical cancers, with Notch as an upstream regulator.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700